TWI274761B - New method to produce a solid form of heparin - Google Patents
New method to produce a solid form of heparin Download PDFInfo
- Publication number
- TWI274761B TWI274761B TW093105873A TW93105873A TWI274761B TW I274761 B TWI274761 B TW I274761B TW 093105873 A TW093105873 A TW 093105873A TW 93105873 A TW93105873 A TW 93105873A TW I274761 B TWI274761 B TW I274761B
- Authority
- TW
- Taiwan
- Prior art keywords
- heparin
- scope
- drum
- salt
- solid form
- Prior art date
Links
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 title claims abstract description 89
- 229920000669 heparin Polymers 0.000 title claims abstract description 89
- 229960002897 heparin Drugs 0.000 title claims abstract description 85
- 238000000034 method Methods 0.000 title claims abstract description 30
- 239000007787 solid Substances 0.000 title claims abstract description 23
- 238000001035 drying Methods 0.000 claims abstract description 19
- 239000002904 solvent Substances 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 150000003839 salts Chemical class 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000003960 organic solvent Substances 0.000 claims description 7
- 210000004185 liver Anatomy 0.000 claims description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 4
- 239000002689 soil Substances 0.000 claims description 2
- -1 tertiary amine salt Chemical class 0.000 claims description 2
- 229910000831 Steel Inorganic materials 0.000 claims 2
- 239000010959 steel Substances 0.000 claims 2
- 241000237858 Gastropoda Species 0.000 claims 1
- 125000003158 alcohol group Chemical group 0.000 claims 1
- 150000001447 alkali salts Chemical class 0.000 claims 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims 1
- 150000001342 alkaline earth metals Chemical class 0.000 claims 1
- 150000003863 ammonium salts Chemical class 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 235000009508 confectionery Nutrition 0.000 claims 1
- 229910017053 inorganic salt Inorganic materials 0.000 claims 1
- 239000008267 milk Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 description 26
- 239000000047 product Substances 0.000 description 17
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 8
- 238000012545 processing Methods 0.000 description 7
- 239000000356 contaminant Substances 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 229920002683 Glycosaminoglycan Polymers 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 229920000045 Dermatan sulfate Polymers 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 229940051593 dermatan sulfate Drugs 0.000 description 3
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012527 feed solution Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 229960001008 heparin sodium Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052751 metal Chemical class 0.000 description 2
- 239000002184 metal Chemical class 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000011877 solvent mixture Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000003039 volatile agent Substances 0.000 description 2
- 102100035353 Cyclin-dependent kinase 2-associated protein 1 Human genes 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229960004676 antithrombotic agent Drugs 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229940018872 dalteparin sodium Drugs 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000002036 drum drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229940087051 fragmin Drugs 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000003055 low molecular weight heparin Substances 0.000 description 1
- 229940127215 low-molecular weight heparin Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/10—Heparin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/12—Powdering or granulating
- C08J3/14—Powdering or granulating by precipitation from solutions
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
- C08J2305/10—Heparin; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45270103P | 2003-03-07 | 2003-03-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200502255A TW200502255A (en) | 2005-01-16 |
| TWI274761B true TWI274761B (en) | 2007-03-01 |
Family
ID=32962743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW093105873A TWI274761B (en) | 2003-03-07 | 2004-03-05 | New method to produce a solid form of heparin |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6933372B2 (enExample) |
| EP (1) | EP1611161B1 (enExample) |
| JP (1) | JP2006519906A (enExample) |
| AR (1) | AR043731A1 (enExample) |
| AT (1) | ATE368057T1 (enExample) |
| CA (1) | CA2517141C (enExample) |
| CL (1) | CL2004000414A1 (enExample) |
| DE (1) | DE602004007784T2 (enExample) |
| ES (1) | ES2289492T3 (enExample) |
| MX (1) | MXPA05009498A (enExample) |
| TW (1) | TWI274761B (enExample) |
| WO (1) | WO2004078791A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
| CN101575385B (zh) * | 2008-05-09 | 2011-01-12 | 青岛九龙生物医药有限公司 | 萃取法分离肝素钠中的多硫酸软骨素的方法 |
| CN101831008B (zh) * | 2009-03-11 | 2013-04-10 | 四川茂森生物科技有限公司 | 粗品肝素钠精制生产新工艺 |
| CN108508129B (zh) * | 2018-04-03 | 2020-11-27 | 青岛海洋生物医药研究院股份有限公司 | 一种肝素类药物生物效价的测定方法 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2034599A (en) | 1933-07-10 | 1936-03-17 | Buffalo Foundry & Machine Co | Method of drying inorganic salts and sludges |
| US2571679A (en) | 1948-07-08 | 1951-10-16 | Carlo Erba S A | Process for preparing purified heparin |
| US2797184A (en) | 1953-07-01 | 1957-06-25 | Upjohn Co | Process for the recovery of heparin |
| US2884358A (en) | 1957-04-22 | 1959-04-28 | Southern California Gland Co | Process for preparing crude heparin |
| US2954321A (en) | 1957-09-23 | 1960-09-27 | Upjohn Co | Process for preparing heparin |
| US3337409A (en) | 1963-11-20 | 1967-08-22 | Rexall Drug Chemical | Process for the recovery of heparin |
| US3330327A (en) * | 1964-03-30 | 1967-07-11 | Continental Oil Co | Drying tertiary amine oxides on extended heated surfaces at elevated temperatures |
| US3817831A (en) | 1973-01-10 | 1974-06-18 | Wilson Pharm & Chem Corp | Process for production of alkali metal salt of heparin |
| CA1136620A (en) | 1979-01-08 | 1982-11-30 | Ulf P.F. Lindahl | Heparin fragments having selective anticoagulation activity |
| US4510135A (en) * | 1982-04-21 | 1985-04-09 | Research Corporation | Orally administered heparin |
| DE3422518A1 (de) * | 1984-06-16 | 1985-12-19 | B. Braun Melsungen Ag, 3508 Melsungen | Heparin-derivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und ihre verwendung bei der behandlung von fettstoffwechselstoerungen |
| DK170015B1 (da) * | 1992-03-19 | 1995-05-01 | Sudurnesja Hitaveita | Saltprodukt samt fremgangsmåde til dets fremstilling |
| US5668118A (en) * | 1992-07-24 | 1997-09-16 | Cavalier Pharmaceuticals | Method of synthesis of 2-O-desulfated Heparin and use thereof for inhibition of elastase and Cathepspin G |
| DE4310088A1 (de) | 1993-03-27 | 1994-09-29 | Hoechst Ag | Verfahren zur Herstellung und Aufarbeitung von in wäßrigem Medium löslichen N-Hydroxyalkylchitosanen |
| AU682792B2 (en) * | 1994-10-13 | 1997-10-16 | Cv Therapeutics, Inc. | Method of manufacturing non-absorbable synthetic sulfated polysaccharides |
| CA2173642C (en) * | 1995-04-10 | 1999-11-02 | James Vincent Gruber | Process for derivatizing polyglucosamines |
| TR200000086T2 (tr) | 1997-07-16 | 2000-08-21 | Akzo Nobel N.V. | Heparin üretimi için işlem. |
| CN1218058A (zh) | 1997-11-26 | 1999-06-02 | 中国林业科学研究院林产化学工业研究所 | 肝素的喷雾干燥方法 |
| US6485945B1 (en) | 1999-02-17 | 2002-11-26 | Nurture, Inc. | Polysaccharide compositions and uses thereof |
| AU3623601A (en) | 2000-02-07 | 2001-08-14 | Granate Seed Ltd | Process for extraction of beta-glucan from cereals and products obtained therefrom |
-
2004
- 2004-02-27 US US10/789,466 patent/US6933372B2/en not_active Expired - Fee Related
- 2004-03-02 CL CL200400414A patent/CL2004000414A1/es unknown
- 2004-03-04 EP EP04717174A patent/EP1611161B1/en not_active Expired - Lifetime
- 2004-03-04 ES ES04717174T patent/ES2289492T3/es not_active Expired - Lifetime
- 2004-03-04 CA CA002517141A patent/CA2517141C/en not_active Expired - Fee Related
- 2004-03-04 JP JP2006506297A patent/JP2006519906A/ja not_active Ceased
- 2004-03-04 WO PCT/IB2004/000625 patent/WO2004078791A1/en not_active Ceased
- 2004-03-04 DE DE602004007784T patent/DE602004007784T2/de not_active Expired - Lifetime
- 2004-03-04 MX MXPA05009498A patent/MXPA05009498A/es active IP Right Grant
- 2004-03-04 AT AT04717174T patent/ATE368057T1/de not_active IP Right Cessation
- 2004-03-05 TW TW093105873A patent/TWI274761B/zh not_active IP Right Cessation
- 2004-03-05 AR ARP040100707A patent/AR043731A1/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| EP1611161B1 (en) | 2007-07-25 |
| ATE368057T1 (de) | 2007-08-15 |
| US20040176581A1 (en) | 2004-09-09 |
| ES2289492T3 (es) | 2008-02-01 |
| DE602004007784T2 (de) | 2007-12-06 |
| EP1611161A1 (en) | 2006-01-04 |
| US6933372B2 (en) | 2005-08-23 |
| CA2517141C (en) | 2008-11-18 |
| MXPA05009498A (es) | 2005-10-18 |
| WO2004078791A1 (en) | 2004-09-16 |
| TW200502255A (en) | 2005-01-16 |
| CL2004000414A1 (es) | 2005-02-04 |
| JP2006519906A (ja) | 2006-08-31 |
| AR043731A1 (es) | 2005-08-10 |
| CA2517141A1 (en) | 2004-09-16 |
| DE602004007784D1 (de) | 2007-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hromadkova et al. | Comparison of classical and ultrasound-assisted extraction of polysaccharides from Salvia officinalis L. | |
| Banga | Thermal contraction of collagen and its dissolution with elastase | |
| BR112014010922B1 (pt) | Processo de extração de polissacarídeos de algas castanhas | |
| JP2018538286A (ja) | 植物からサポニンを得る方法 | |
| BR112019017527B1 (pt) | Pentosano polissulfato, composição farmacêutica, anticoagulante,e, uso do pentosano polissulfato | |
| TWI274761B (en) | New method to produce a solid form of heparin | |
| JPH01230519A (ja) | ポリ硫酸化ヘパリンの用途 | |
| TWI247751B (en) | Sulfated fucogalactan | |
| PT91203B (pt) | Processo para a preparacao de novos derivados de antibioticos bu-3608 e de composicoes farmaceuticas que os contem | |
| TWI344986B (en) | A process for preparing dry yeast containing s-adenosyl-l-methionine and an oral composition | |
| Tang et al. | CO2-responsive ionic liquid for the sustainable extraction and separation of Rosa roxburghii polysaccharides | |
| FI125039B (fi) | Sellobioosin puhdistusmenetelmä ja valmistusmenetelmä | |
| CN106617115B (zh) | 从罗汉果生产废液中分离可溶性膳食纤维的方法 | |
| JP2015510025A (ja) | 元玉および樹皮を含む針葉樹の材種または硬材から食物繊維であるアラビノガラクタンおよびフラボノイドであるジヒドロケルセチン（タキシホリン）を伴うアラビノガラクタンを単離するための方法 | |
| Abbasi et al. | Benzothiazole derivatives: novel inhibitors of methylglyoxal mediated glycation of proteins in vitro | |
| CN108753872A (zh) | 一种莲子多糖高收率的提取方法 | |
| CN102936291A (zh) | 一种硒化聚甘露糖醛酸制备方法及其应用 | |
| JPS6121102A (ja) | キトサンオリゴ糖の製造法 | |
| RU2311954C2 (ru) | Энтеросорбент и способ его получения | |
| KR101878348B1 (ko) | 인삼 사포닌 함량이 증가된 흑삼 제조방법 | |
| JP2892624B2 (ja) | グリコサミノグリカンの抽出方法とそれによる皮膚の角質層の改善剤 | |
| WO2017169311A1 (ja) | ネポジン高含有ギシギシ抽出物の製造方法及びネポジン高含有ギシギシ抽出物 | |
| CN106832031A (zh) | 车前子多糖提取物的制备方法 | |
| KR101813920B1 (ko) | 판크레아틴의 살균방법 및 이를 이용한 판크레아틴 제조방법 | |
| GB734624A (en) | Bactericidal and similar compositions comprising cellulose ether carrier material |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |